Log In
Print
BCIQ
Print
Print this Print this
 

NT0202

  Manage Alerts
Collapse Summary General Information
Company Neos Therapeutics Inc.
DescriptionOnce-daily, extended-release, oral tablet formulation of amphetamine polistirex that uses Neos' Rapidly Disintegrating Ionic Masking (RDIM) technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat attention deficit hyperactivity disorder (ADHD)
Regulatory Designation

U.S. - Standard Review (Treat attention deficit hyperactivity disorder (ADHD))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today